Abstract
Angiogenesis is the process by which new vessels are generated from the preexisting blood vessels, which is the major contributor of postnatal neovascularization process. Disruption or dysregulation of angiogenesis is involved in various pathological conditions, such as ischemia and tumor progression. Stimulation of angiogenesis was proposed to be able to restore the blood flow and contribute to the tissue recovery in ischemia, while inhibition of angiogenesis can impede tumor progression. The importance of angiogenesis has generated tremendous interest in studying the mechanisms and to find out major contributors of the process. The current stem cell research has significantly improved our understanding of angiogenesis and its possible therapeutic application. Hypoxia is the most important driving force of angiogenesis, while other factors, such as chemokines and cytokines, haptotaxis, and mechanotaxis, are also important in regulating neovascularization process. In this chapter, we will focus on the progenitor cells that contribute to the angiogenesis and the underlining mechanisms involved in this process.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Patan S (2000) Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 50:1–15
Halperin JL (2002) Evaluation of patients with peripheral vascular disease. Thromb Res 106:V303–V311
Lee JS, Hong JM, Moon GJ et al (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099–1106
Kwon SM, Lee YK, Yokoyama A et al (2011) Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J Mol Cell Cardiol 51:308–317
Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685–693
Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Kovacic JC, Moore J, Herbert A et al (2008) Endothelial progenitor cells, angioblasts, and angiogenesis—old terms reconsidered from a current perspective. Trends Cardiovasc Med 18:45–51
Hattori K, Dias S, Heissig B et al (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005–1014
Rajantie I, Ilmonen M, Alminaite A et al (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084–2086
Hur J, Yoon CH, Kim HS et al (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288–293
Vogeli KM, Jin SW, Martin GR, Stainier DY (2006) A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 443:337–339
Takakura N, Watanabe T, Suenobu S et al (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199–209
Melero-Martin JM, De Obaldia ME, Allen P et al (2010) Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. Tissue Eng Part A 16:2457–2466
Jin DK, Shido K, Kopp HG et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4(+) hemangiocytes. Nat Med 12:557–567
Melero-Martin JM, Dudley AC (2011) Concise review: vascular stem cells and tumor angiogenesis. Stem Cells 29:163–168
Au P, Tam J, Fukumura D, Jain RK (2008) Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111:4551–4558
Sanz L, Santos-Valle P, Alonso-Camino V et al (2008) Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 75:308–314
Kim SW, Kim H, Yoon YS (2011) Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med 6:335–349
Nih LR, Deroide N, Lere-Dean C et al (2012) Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration. Eur J Neurosci 35:1208–1217
Pardali E, ten Dijke P (2009) Transforming growth factor-beta signaling and tumor angiogenesis. Front Biosci 14:4848–4861
Okuda Y, Tsurumaru K, Suzuki S et al (1998) Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells. Life Sci 63:477–484
Crisan M, Yap S, Casteilla L et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313
Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313–319
Lamalice L, Le Boeuf F, Huot J (2007) Endothelial cell migration during angiogenesis. Circ Res 100:782–794
Brogi E, Schatteman G, Wu T et al (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469–476
Chua CC, Hamdy RC, Chua BH (1998) Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25:891–897
Barleon B, Siemeister G, Martiny-Baron G et al (1997) Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421–5425
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling—in control of vascular function. Nat Rev Mol Cell Biol 7:359–371
Shalaby F, Rossant J, Yamaguchi TP et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66
Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19:2003–2012
Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549–560
Mukouyama YS, Gerber HP, Ferrara N et al (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132:941–952
Lawson ND, Vogel AM, Weinstein BM (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3:127–136
Matsui M, Tabata Y (2012) Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater 8:1792–1801
Hildbrand P, Cirulli V, Prinsen RC et al (2004) The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 104:2010–2019
Iurlaro M, Scatena M, Zhu WH et al (2003) Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. J Cell Sci 116:3635–3643
Zhu G, Huang L, Song M et al (2010) Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation. Int J Cardiol 138:70–80
Schroder K, Schutz S, Schloffel I et al (2011) Hepatocyte growth factor induces a proangiogenic phenotype and mobilizes endothelial progenitor cells by activating Nox2. Antioxid Redox Signal 15:915–923
Yang ZJ, Ma DC, Wang W et al (2006) Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 13:1564–1568
Salcedo R, Resau JH, Halverson D et al (2000) Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 14:2055–2064
Addison CL, Daniel TO, Burdick MD et al (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269–5277
Devalaraja RM, Nanney LB, Du J et al (2000) Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 115:234–244
Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280:L1094–L1103
Salcedo R, Wasserman K, Young HA et al (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125–1135
Real C, Caiado F, Dias S (2008) Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do? Cardiovasc Hematol Disord Drug Targets 8:185–193
Chavakis E, Aicher A, Heeschen C et al (2005) Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201:63–72
Jin H, Su J, Garmy-Susini B et al (2006) Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 66:2146–2152
Qin G, Ii M, Silver M et al (2006) Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med 203:153–163
Chavakis E, Hain A, Vinci M et al (2007) High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 100:204–212
Carmona G, Chavakis E, Koehl U et al (2008) Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 111:2640–2646
Li S, Huang NF, Hsu S (2005) Mechanotransduction in endothelial cell migration. J Cell Biochem 96:1110–1126
Noria S, Cowan DB, Gotlieb AI, Langille BL (1999) Transient and steady-state effects of shear stress on endothelial cell adherens junctions. Circ Res 85:504–514
Albuquerque ML, Waters CM, Savla U et al (2000) Shear stress enhances human endothelial cell wound closure in vitro. Am J Physiol Heart Circ Physiol 279:H293–H302
Azuma N, Akasaka N, Kito H et al (2001) Role of p38 MAP kinase in endothelial cell alignment induced by fluid shear stress. Am J Physiol Heart Circ Physiol 280:H189–H197
Birukov KG, Birukova AA, Dudek SM et al (2002) Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 26:453–464
Wojciak-Stothard B, Ridley AJ (2003) Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J Cell Biol 161:429–439
Ramirez-Bergeron DL, Runge A, Dahl KDC et al (2004) Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131:4623–4634
Du R, Lu KV, Petritsch C et al (2008) HIF1 alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206–220
Abdollahi H, Harris LJ, Zhang P et al (2011) The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res 165:112–117
Thangarajah H, Vial IN, Chang E et al (2009) IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 27:266–274
Cao Y, Sun Z, Liao L et al (2005) Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332:370–379
Weidemann A, Johnson RS (2008) Biology of HIF-1alpha. Cell Death Differ 15:621–627
Radtke F, Wilson A, Mancini SJ, MacDonald HR (2004) Notch regulation of lymphocyte development and function. Nat Immunol 5:247–253
Iso T, Kedes L, Hamamori Y (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194:237–255
Fischer A, Schumacher N, Maier M et al (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901–911
Liu ZJ, Xiao M, Balint K et al (2006) Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20:1009–1011
Pola R, Ling LE, Silver M et al (2001) The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 7:706–711
Kanda S, Mochizuki Y, Suematsu T et al (2003) Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J Biol Chem 278:8244–8249
Hochman E, Castiel A, Jacob-Hirsch J et al (2006) Molecular pathways regulating pro-migratory effects of Hedgehog signaling. J Biol Chem 281:33860–33870
Asai J, Takenaka H, Kusano KF et al (2006) Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113:2413–2424
Nicoli S, Standley C, Walker P et al (2010) MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464:1196–1200
Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100:1164–1173
Suarez Y, Fernandez-Hernando C, Yu J et al (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 105:14082–14087
Howard L, Kane NM, Milligan G, Baker AH (2011) MicroRNAs regulating cell pluripotency and vascular differentiation. Vascul Pharmacol 55:69–78
Tongers J, Roncalli JG, Losordo DW (2010) Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 79:200–206
Shumiya T, Shibata R, Shimizu Y et al (2010) Evidence for the therapeutic potential of ex vivo expanded human endothelial progenitor cells using autologous serum. Circ J 74:1006–1013
Wollert KC, Drexler H (2010) Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 7:204–215
Acknowledgements
This work was supported in part by National Institutes of Health grants, K01 AR054114 (NIAMS), SBIR R44 HL092706-01 (NHLBI), R21 CA143787 (NCI), Pelotonia idea award and the Ohio State University start-up fund for stem cell research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lu, J., Pompili, V.J., Das, H. (2013). Vascular Stem Cells in Regulation of Angiogenesis. In: Mehta, J., Dhalla, N. (eds) Biochemical Basis and Therapeutic Implications of Angiogenesis. Advances in Biochemistry in Health and Disease, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5857-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5857-9_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5856-2
Online ISBN: 978-1-4614-5857-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)